MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer

MINDY1 is a Downstream Target of the Polyamines and Promotes Embryonic Stem Cell Self-Renewal

(2018) Christina James et al.   STEM CELLS

Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin

(2018) Byunghee Yoo et al.   PLoS One

MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes

(2017) Can Liu et al.   Nature Communications

Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer

(2017) Byunghee Yoo et al.   Scientific Reports

Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms

(2017) Kristina Endres et al.   Frontiers in Molecular Neuroscience

Molecular Concordance Between Primary Breast Cancer and Matched Metastases

(2016) Anne Bruun Krøigård et al.   Breast Journal

Integrated analysis of noncoding RNAs and mRNAs reveals their potential roles in the biological activities of the growth hormone receptor

(2016) Lei Chang et al.   GROWTH HORMONE & IGF RESEARCH

Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring

(2015) Andrew McGuire et al.   CANCER AND METASTASIS REVIEWS

Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer

(2015) B. Yoo et al.   CANCER RESEARCH

Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells

(2015) Devon A. Lawson et al.   NATURE

Predicting effective microRNA target sites in mammalian mRNAs

(2015) Vikram Agarwal et al.   eLife

miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2

(2014) Jing Y. Krzeszinski et al.   NATURE

miRDB: an online resource for microRNA target prediction and functional annotations

(2014) Nathan Wong et al.   NUCLEIC ACIDS RESEARCH

Distinct Effects of Ligand-Induced PDGFR  and PDGFR  Signaling in the Human Rhabdomyosarcoma Tumor Cell and Stroma Cell Compartments

(2013) M. Ehnman et al.   CANCER RESEARCH

Sequence-dependent combination therapy with doxorubicin and a survivin-specific small interfering RNA nanodrug demonstrates efficacy in models of adenocarcinoma

(2013) Subrata K. Ghosh et al.   INTERNATIONAL JOURNAL OF CANCER

Design of Nanodrugs for miRNA Targeting in Tumor Cells

(2013) Byunghee Yoo et al.   Journal of Biomedical Nanotechnology

miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis

(2013) Yun Zhang et al.   NATURE CELL BIOLOGY

Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis

(2012) M V Yigit et al.   ONCOGENE

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

(2011) Can Liu et al.   NATURE MEDICINE

Image-Guided Breast Tumor Therapy Using a Small Interfering RNA Nanodrug

(2010) M. Kumar et al.   CANCER RESEARCH

MicroRNA-206 Targetsnotch3, Activates Apoptosis, and Inhibits Tumor Cell Migration and Focus Formation

(2009) Guisheng Song et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

(2009) Da Wei Huang et al.   Nature Protocols

Endogenous human microRNAs that suppress breast cancer metastasis

(2008) Sohail F. Tavazoie et al.   NATURE

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

(2008) Philip A. Gregory et al.   NATURE CELL BIOLOGY

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

(2008) Da Wei Huang et al.   NUCLEIC ACIDS RESEARCH